María Saumoy-Linares

6PUBLICATIONS
17CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityRespiratory diseasesMajor global burdens of diseaseCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 12, 2026
Long-Term Risk of Residual or Recurrent CIN 2-3 After LLETZ in Immunosuppressed vs. Immunocompetent Women: A 20-Year Cohort Study.

|Mar 06, 2026
Inflammatory Biomarkers Decay After First-Line Antiretroviral Therapy Initiation With Dolutegravir/Lamivudine or Bictegravir/Emtricitabine/Tenofovir Alafenamide in Persons With HIV: A Substudy of a Randomized Clinical Trial.

Analuz Fernandez, Sofía Scevola, Raul Rigo Bonin

|Mar 25, 2025
Biomarkers of inflammation and coagulation predict non-AIDS-defining events in a prospective cohort of virologically suppressed people living with HIV.

Maria Saumoy, Analuz Fernandez, Juan Tiraboschi

|Dec 13, 2023
Predictors of poor health-related quality of life among people living with HIV aged ≥60 years in the PISCIS cohort: Findings from the Vive+ project.

Andreu Bruguera, L Egea-Cortés, J Mesías-Gazmuri

|Apr 05, 2021
Carotid atherosclerosis in virologically suppressed HIV patients: comparison with a healthy sample and prediction by cardiovascular risk equations.

M Saumoy, S Di Yacovo, S Pérez

|Aug 21, 2020
Lipids, biomarkers, and subclinical atherosclerosis in treatment-naive HIV patients starting or not starting antiretroviral therapy: Comparison with a healthy control group in a 2-year prospective study.

Silvana Di Yacovo, Maria Saumoy, José Luís Sánchez-Quesada

Pageof 1

Frequent Collaborators

2 joint publications

Juan Tiraboschi

2 joint publications

Arkaitz Imaz

2 joint publications

Analuz Fernandez

1 joint publications

Andreu Bruguera